Table 4.
FAC−MS Data in Comparison with [35S]GTPyS Binding Results Obtained on GPR17-IAM-II and Mutated GPR17-IAMa
GPR17-IAM-II |
mutated-GPR17-IAM |
|||||
---|---|---|---|---|---|---|
compd | tb (min) | EC 50 | IC50 c(nM) | tb (min) | EC50 | IC50c (nM) |
UDP | 2.69 | 1.14 ± 0.2/µM | 2.15 | 3.0 ± 0.3 µM | ||
13 | 2.79 | 945 ± 48 nM | 2.51 | 1.87 ± 0.20 µM | ||
12 | 3.55 | 582 ± 57 | ||||
MRS2179 | 3.62 | 508 ± 29 | 3.47 | 227 ± 22 | ||
5 | 3.69 | 112 ± 7 | ||||
7 | 4.5 | 11 ± 1 nM | ||||
8 | 4.77 | 1.7 ± 0.1 nM | ||||
6 | 5.67 | 1.4 ± 0.1 nM | ||||
cangrelor | 10.6 | 0.7 ± 0.02 | 13.16 | 0.15 ±0.01 | ||
4 | 13.07 | 36 ± 3 pM | 16.07 | 25.4 ± 1.0 pM |
Columns: GPR17-IAM-II (19.5 million cells), mutated GPR17-IAM (19.5 million cells)
t is the breakthrough time of the ligand with the immobilized GPR17.
Versus UDP-glucose 10 µM.